Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Frontiers in Immunology
|
March 3, 2020
Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types
Eric D Routh, Ashok K Pullikuth, Guangxu Jin, et al.
Journal of Translational Medicine
|
November 20, 2024
A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers
Laurel K Berry, Ashok K Pullikuth, Kristen L Stearns, et al.
Genome Biology
|
April 27, 2013
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
Srikanth Nagalla, Jeff W Chou, Mark C Willingham, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 24, 2016
Effects of Pubertal Exposure to Dietary Soy on Estrogen Receptor Activity in the Breast of Cynomolgus Macaques
Fitriya N Dewi, Charles E Wood, Cynthia J Willson, et al.
Iscience
|
May 20, 2020
Solute Carrier Family 37 Member 2 (SLC37A2) Negatively Regulates Murine Macrophage Inflammation by Controlling Glycolysis
Zhan Wang, Qingxia Zhao, Yan Nie, et al.
Nature Communications
|
March 31, 2022
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Rebecca Anderson, Lance D Miller, Scott Isom, et al.
BMC Genomics
|
June 14, 2008
Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories
Michael J Boedigheimer, Russell D Wolfinger, Michael B Bass, et al.
American Journal of Nephrology
|
September 8, 2015
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression
Gregory A Hawkins, David J Friedman, Lingyi Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
Timothy S Pardee, Rebecca G Anderson, Kristin M Pladna, et al.
Journal of the American Society of Nephrology : JASN
|
November 9, 2016
<i>APOL1</i> Renal-Risk Variants Induce Mitochondrial Dysfunction
Lijun Ma, Jeff W Chou, James A Snipes, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Frontiers in Immunology
|
March 3, 2020
Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types
Eric D Routh, Ashok K Pullikuth, Guangxu Jin, et al.
Journal of Translational Medicine
|
November 20, 2024
A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers
Laurel K Berry, Ashok K Pullikuth, Kristen L Stearns, et al.
Genome Biology
|
April 27, 2013
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
Srikanth Nagalla, Jeff W Chou, Mark C Willingham, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 24, 2016
Effects of Pubertal Exposure to Dietary Soy on Estrogen Receptor Activity in the Breast of Cynomolgus Macaques
Fitriya N Dewi, Charles E Wood, Cynthia J Willson, et al.
Iscience
|
May 20, 2020
Solute Carrier Family 37 Member 2 (SLC37A2) Negatively Regulates Murine Macrophage Inflammation by Controlling Glycolysis
Zhan Wang, Qingxia Zhao, Yan Nie, et al.
Nature Communications
|
March 31, 2022
Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Rebecca Anderson, Lance D Miller, Scott Isom, et al.
BMC Genomics
|
June 14, 2008
Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories
Michael J Boedigheimer, Russell D Wolfinger, Michael B Bass, et al.
American Journal of Nephrology
|
September 8, 2015
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression
Gregory A Hawkins, David J Friedman, Lingyi Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2018
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
Timothy S Pardee, Rebecca G Anderson, Kristin M Pladna, et al.
Journal of the American Society of Nephrology : JASN
|
November 9, 2016
<i>APOL1</i> Renal-Risk Variants Induce Mitochondrial Dysfunction
Lijun Ma, Jeff W Chou, James A Snipes, et al.
Page
of 4